tiprankstipranks
Trending News
More News >
Noram Lithium Corp (TSE:NRM)
:NRM

Noram Lithium Corp (NRM) AI Stock Analysis

Compare
28 Followers

Top Page

TSE:NRM

Noram Lithium Corp

(NRM)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - 5.2)
Rating:47Neutral
Price Target:
C$0.14
▲(30.00% Upside)
The score is primarily held back by weak financial performance (no revenue, ongoing losses, and negative free cash flow), partly offset by a low-debt balance sheet. Technical indicators are broadly neutral with limited momentum, while valuation signals remain constrained by negative earnings and no dividend yield support.
Positive Factors
Low leverage balance sheet
A very low debt-to-equity ratio (~0.03) materially reduces near-term solvency risk and interest burdens, giving management flexibility in capital allocation and preserving optionality to pursue project studies or partnerships before taking on meaningful project debt.
Strategic project location
Hosting the Zeus Lithium Project in Clayton Valley places the company in a proven, lithium-rich jurisdiction with established supply-chain infrastructure and permitting experience. This location advantage supports longer-term development potential and partner interest versus remote projects.
Improving loss trajectory
A narrowing net loss indicates better cost control or more efficient capital deployment, reducing the company's structural burn rate. If sustained, this trend lengthens runway between financings and improves prospects for advancing technical work toward a commercial decision.
Negative Factors
Pre-revenue operations with cash burn
The company remains pre-revenue and generates negative operating and free cash flow, meaning operations are not self-funding. Persistent cash burn forces reliance on external capital and constrains the pace of exploration, permitting, and project de-risking over the medium term.
Reliance on capital markets financing
Ongoing dependence on equity issuances and financings is structurally dilutive and exposes the firm to market-access risk. In periods of wider investor aversion, the company could face funding delays that slow project advancement or force more dilutive terms.
Erosion of shareholders' equity
Material declines in equity and total assets reflect cumulative losses and capital consumption, weakening the balance sheet cushion. A shrinking equity base can limit access to non-dilutive financing, increase perceived project risk for partners, and raise long-term funding costs.

Noram Lithium Corp (NRM) vs. iShares MSCI Canada ETF (EWC)

Noram Lithium Corp Business Overview & Revenue Model

Company DescriptionNoram Lithium Corp. engages in the acquisition, exploration, and development of mineral properties in the United States. Its flagship property is the Zeus Lithium project that covers an area of approximately 1,113 hectares located in Clayton Valley, Nevada. The company was formerly known as Noram Ventures Inc. and changed its name to Noram Lithium Corp. in July 2021. Noram Lithium Corp. was incorporated in 2010 and is headquartered in Vancouver, Canada.
How the Company Makes MoneyNoram Lithium Corp makes money through the exploration and potential development of lithium resources. The company's revenue model is primarily based on the identification and enhancement of lithium properties, which are then either developed into operational mines or sold to larger mining entities. Key revenue streams include the sale of lithium, either directly or through joint ventures and partnerships with other mining companies. Additionally, Noram Lithium may generate income through strategic partnerships or agreements that provide funding for exploration activities in exchange for a stake in the projects or future lithium supply. Factors such as lithium market prices, successful resource discoveries, and favorable regulatory environments significantly contribute to its earnings potential.

Noram Lithium Corp Financial Statement Overview

Summary
Pre-revenue with continued losses (TTM net income -2.31M) and ongoing cash burn (TTM operating cash flow -744K; free cash flow -770K). A key positive is low leverage (debt ~116.7K vs equity 4.58M; ~0.03 debt-to-equity), but equity/assets have been declining, implying continued reliance on external funding until commercialization.
Income Statement
12
Very Negative
TTM (Trailing-Twelve-Months) results show no revenue and continued losses, with net income at -2.31M and negative gross profit, indicating the company is still pre-commercial and absorbing ongoing operating costs. Losses have narrowed versus the prior annual period (net loss improved from -3.15M in FY2025 to -2.31M TTM), which is a modest positive trajectory, but profitability remains structurally weak until revenues begin.
Balance Sheet
62
Positive
The balance sheet is conservatively levered, with low debt (116.7K TTM) relative to equity (4.58M) and a very low debt-to-equity ratio (~0.03), which reduces solvency risk. However, equity and total assets have trended down from prior years (equity fell from 13.55M in FY2023 to 5.79M in FY2025 and 4.58M TTM), consistent with ongoing losses and cash usage, and returns on equity remain meaningfully negative.
Cash Flow
18
Very Negative
Cash generation remains a key weakness: TTM operating cash flow is -744K and free cash flow is -770K, reflecting continued cash burn. Cash burn has improved versus FY2025 (operating cash flow -2.19M), but free cash flow growth is sharply negative in the TTM period, and cash flow is still not self-funding given persistent operating losses.
BreakdownTTMDec 2024Dec 2024Dec 2022Dec 2022Dec 2021
Income Statement
Total Revenue0.000.000.000.000.000.00
Gross Profit-53.61K-56.73K-56.77K-59.61K-56.21K-55.81K
EBITDA-2.25M-6.30M-3.09M-5.26M-5.17M-4.93M
Net Income-2.31M-5.66M-3.15M-5.32M-4.18M-5.01M
Balance Sheet
Total Assets5.77M8.43M6.30M5.94M14.24M5.04M
Cash, Cash Equivalents and Short-Term Investments3.53K3.64M577.36K1.60M12.22M1.62M
Total Debt116.65K55.68K151.05K160.88K110.90K50.60K
Total Liabilities1.19M480.54K511.87K550.13K694.47K341.03K
Stockholders Equity4.58M7.95M5.79M5.39M13.55M4.70M
Cash Flow
Free Cash Flow-769.73K-4.88M-2.19M-2.39M-5.99M-1.31M
Operating Cash Flow-743.98K-4.88M-2.19M-1.64M-3.97M-1.07M
Investing Cash Flow-32.72K4.33M1.83M-1.50M-11.17M-990.16K
Financing Cash Flow-43.06K-63.30K-24.83K2.37M16.61M2.92M

Noram Lithium Corp Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.11
Price Trends
50DMA
0.11
Positive
100DMA
0.12
Positive
200DMA
0.11
Positive
Market Momentum
MACD
<0.01
Negative
RSI
72.20
Negative
STOCH
83.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NRM, the sentiment is Positive. The current price of 0.11 is below the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.11, and above the 200-day MA of 0.11, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 72.20 is Negative, neither overbought nor oversold. The STOCH value of 83.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:NRM.

Noram Lithium Corp Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
51
Neutral
C$10.22M-33.33-1.36%-136.00%
49
Neutral
C$23.65M-72.2916.97%
47
Neutral
C$12.52M-5.43-41.21%48.66%
47
Neutral
C$7.89M-4.74-121.94%55.15%
46
Neutral
C$16.09M-3.63-105.74%40.18%
33
Underperform
C$15.78M-7.53-17.86%92.11%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:NRM
Noram Lithium Corp
0.14
0.04
40.00%
TSE:ILI
Imagine Lithium Inc
0.03
<0.01
50.00%
TSE:MUR
Murchison Minerals
0.38
0.18
90.95%
TSE:SRA
Stria Lithium
0.60
0.53
757.14%
TSE:GRG
Golden Arrow Resources
0.10
0.04
58.33%
TSE:AWCM
Ameriwest Lithium
0.58
0.51
673.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026